A Retrospective Evaluation of Superficial Radiation Therapy (SRT) and Keloid Scars.
Sponsored by Sensus Healthcare
About this trial
Last updated 7 years ago
Study ID
SRTS-SRT-002
Status
Unknown status
Type
Observational
Placebo
No
Accepting
18+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 6 years ago
What is this trial about?
Keloid formation in response to skin trauma inflicts about 18 million individuals. A key
impediment in successful treatment of keloids is that the predominant treatments,
particularly surgical excision and shaving, tend to initiate the regrowth of the keloid
at the excision site, and therefore, recurrence rates are high. There is much evidence to
demonstrate that following surgical excision procedures with a course of radiation
therapy can significantly reduce recurrence rates to as little as 10% or below. This
retrospective study is to evaluate this claim.
What are the participation requirements?
Inclusion Criteria
- Confirmed diagnosis of keloid(s).
- Treatment with SRT-100™ of one or more keloids.
- At least 1 year since treatment end.
- Required retrospective data is existing and sufficient.
Exclusion Criteria
- Lesions of etiology other than keloids.